Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Jun;35(5):511-8.
doi: 10.1007/s11055-005-0086-1.

Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze

Affiliations
Comparative Study

Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze

M Yu Stepanichev et al. Neurosci Behav Physiol. 2005 Jun.

Abstract

Decreases in cognitive functions, particularly long-term (episodic) and working memory, are among the earliest prognostic signs of Alzheimer's disease. The toxicity of beta-amyloid peptide is regarded as a major cause of neurodegeneration and cognitive impairment in this disease. The present report describes studies of the effects of intracerebroventricular administration of beta-amyloid peptide (25-35) (Abeta(25-35)) on the reproduction of a previously assimilated habit consisting of finding food in an eight-arm radial maze in rats. Abeta(25-35) was given bilaterally at doses of 15 and 30 nmol/animal seven days after preliminary training. Testing was performed 60 days after peptide administration. The results showed that Abeta(25-35) impaired working memory in rats without having any significant effect on the retention of responses. We were unable to demonstrate any relationship between memory impairment and the dose of peptide given. These data provide evidence of the ability of Abeta(25-35) to produce greater degradation of working memory function than long-term memory function.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res Bull. 1998;45(4):405-11 - PubMed
    1. Brain Res. 1994 Feb 4;636(1):162-4 - PubMed
    1. Eur J Pharmacol. 1997 Jan 14;319(1):1-4 - PubMed
    1. FASEB J. 2001 Nov;15(13):2433-44 - PubMed
    1. J Neurosci. 2001 Aug 1;21(15):5703-14 - PubMed

Publication types

LinkOut - more resources